Study of blood and genetic features in new CLL patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at blood tests and genetic markers in people newly diagnosed with chronic lymphocytic leukemia (CLL). It aims to better understand the disease and may help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been recently diagnosed with CLL (chronic lymphocytic leukemia).
- You must have had certain blood tests (flow cytometry) and genetic tests (cytogenetics) done as part of your diagnosis.
- You must be willing to let the researchers use your medical information and have follow-up data for at least 1 year after diagnosis.
- You must sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates lab models from blood samples of people with specific mature B-cell blood cancers (CLL, SMZL, HCL) to test new immune and combination treatments. This research may help find more personalized therapies for these diseases.
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
This trial looks at blood cell changes in people newly diagnosed with a chronic lymphoproliferative disorder (a type of blood cancer) or a viral hepatitis infection. It may help doctors understand how these conditions affect blood cell counts.
This study looks at a specific gene variant in people with newly diagnosed chronic lymphocytic leukemia (CLL). It may help researchers understand CLL better and how genetics could affect the disease.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
Hear when a new Chronic Lymphocytic Leukemia (CLL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.